Alison Frankel is reporting claims that the last major chunk of the Seroquel litigation is settling confidentially at the nuisance rate of about $92 million for 2300 claims (after the first 25000 or so cases settled for an even smaller $647 million). These are figures that reflect avoiding the costs of defense rather than any risk of loss. Some plaintiffs who envisioned big pots of gold after being recruited by firms that advertised for Seroquel plaintiffs and then had their claims sold en masse to the chicken pluckers are disgruntled, but mass-tort litigation is designed to benefit the attorneys, rather than any plaintiffs, victims or otherwise. (Separately, I find it fascinating that attorneys are not allowed to hire runners to recruit clients—with the result that some attorneys effectively act as "chicken-catchers" indistinguishable from runners.)
Seroquel mass tort settlement?
Related Entries:
- Deep pocket files: Scott Simon and Harding Pharmacy
- New podcasts from the Manhattan Institute
- Event video featuring Kenneth R. Feinberg: Is America's legal system broken?
- Around the web, January 27
- California rejects tertiary asbestos liability in O'Neill v. Crane
- Trask on Prakash
- Around the web, December 15
- Preempro jackpot justice verdicts in Philadelphia
- What media bias? Prakash on Penn State
- Lobbying expenditures
- Johnson & Johnson lawsuit thrown out
- Gryphon on Prakash on Vioxx
- Liability for thee, but not for me
- Around the web, September 9
- Around the web, August 31
![]() |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
![]() |
| Laura Eyi Press Officer, Manhattan Institute leyi@manhattan-institute.org |



